Dr. Aaron Tan is a researcher based in University College London (UCL) Medical School, and is a visiting scholar at the Biomaterials and Advanced Drug Delivery Laboratory (BioADD) at Stanford University. He graduated with a BSc in Surgical Sciences from UCL in 2011, and was awarded his PhD in Surgery and Bioengineering from UCL in 2014. Dr. Aaron Tan is currently completing the clinical years of his MBBS Medicine degree at UCL Medical School. He has held research collaboration positions at various top institutions including Harvard University, University of Oxford, and Imperial College London. To date, he has authored in excess of 40 PubMed-indexed publications, with papers in high-impact factor journals including ACS Nano, Trends in Biotechnology, Advanced Drug Delivery Reviews, among many others. He has 1090 citations, and a h-index of 16. He is a Guest Editor at Frontiers in Pharmacology, and Nano Reviews and Experiments. He works on the forefront of nanotechnology and regenerative therapeutics as applied to clinical medicine and surgery. 

Advanced Drug Delivery, Biotechnology, Nanotechnology and Regenerative therapeutics as applied to Clinical medicine and Surgery